NAAG Inhibits Pain Processing in the Amygdala
Author Information
Author(s): Adedoyin Mary O, Vicini Stefano, Neale Joseph H
Primary Institution: Georgetown University
Hypothesis
NAAG influences pain processing in the amygdala.
Conclusion
NAAG and its peptidase inhibition reduce excitatory neurotransmission and inflammation-induced plasticity in the amygdala's pain processing pathway.
Supporting Evidence
- NAAG peptidase inhibition reduced synaptic release of glutamate.
- ZJ43 treatment blocked the development of mechanical allodynia.
- NAAG's effects were reversed by the group II mGluR antagonist LY341495.
Takeaway
NAAG helps control pain signals in the brain, and blocking its breakdown can reduce pain sensitivity.
Methodology
The study used a mouse model of inflammatory pain to assess the effects of NAAG and its peptidase inhibitor on synaptic transmission in the amygdala.
Limitations
The study primarily focused on a specific mouse model and may not generalize to other pain models or species.
Participant Demographics
Adult male C57BL/6 mice.
Statistical Information
P-Value
p = 0.003; p = 0.02; p < 0.001; p < 0.04
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website